CookiesThis site uses cookies to analyze site interaction in order to improve the quality of service and ensure smooth operation of the site. In more detail in Cookies policy
A specialized edition intended for medical institutions and doctors.

Gentamicin sulfate-Darnitsa

Systemic antimicrobial agents. Aminoglycosides. Gentamicin
Considering the limited margin of safety of Gentamicin-Darnitsa, it should be used when the microorganisms are resistant to safer antibiotics. Bacterial infections caused by gentamicin-sensitive microflora, in particular, lower respiratory infections, complicated urogenital infections, bone and joint infections, in particular, osteomyelitis, skin and soft tissue infections, infected burns, abdominal infections (peritonitis), central nervous system infections, in particular, meningitis in combination with β-lactam antibiotics, septicemia.
Characteristics of the productу:
    • Release formInjectable solution
    • ChildrenAllowed
    • PregnantContraindicated
    • NursingContraindicated
    • Release categoryPrescription medication
    • DriversContraindicated
    • Temperature storage conditionsNot higher than 25 °С
    • Qualitative and quantitative composition
    • Pharmaceutical form
    • Pharmacotherapeutic group
    • Pharmacological properties
    • Clinical particulars
    • Therapeutic indications
    • Contraindications
    • Interaction with other medicinal products and other forms of interaction
    • Special warnings and precautions for use
    • Posology and method of administration
    • Overdose
    • Undesirable effects
    • Shelf life
    • Special precautions for storage
    • Incompatibilities
    • Nature and contents of container
    • Category of release
    • Manufacturer/Applicant
    • The manufacturer's location and address of the place of business
    • Date of the last revision